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Abstract
A comprehensive view of brain inflammation during the pathogenesis of autoimmune encephalomyelitis can be achieved
with the aid of high resolution non-invasive imaging techniques such as microscopic magnetic resonance imaging (mMRI). In
this study we demonstrate the benefits of cryogenically-cooled RF coils to produce mMRI in vivo, with sufficient detail to
reveal brain pathology in the experimental autoimmune encephalomyelitis (EAE) model. We could visualize inflammatory
infiltrates in detail within various regions of the brain, already at an early phase of EAE. Importantly, this pathology could be
seen clearly even without the use of contrast agents, and showed excellent correspondence with conventional histology.
The cryogenically-cooled coil enabled the acquisition of high resolution images within short scan times: an important
practical consideration in conducting animal experiments. The detail of the cellular infiltrates visualized by in vivo mMRI
allows the opportunity to follow neuroinflammatory processes even during the early stages of disease progression. Thus
mMRI will not only complement conventional histological examination but will also enable longitudinal studies on the
kinetics and dynamics of immune cell infiltration.
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Introduction
Inflammatory diseases of the central nervous system (CNS) such as
multiple sclerosis (MS) involve a recruitment of immune cells during
the early stages of pathogenesis, prior to the onset of clinical
symptoms [1–3]. Normally the blood-brain barrier (BBB) restricts
migration of immune cells to the CNS, but during inflammation its
function becomes altered. Immune cells gain access to CNS
parenchyma via a complex, multi-step process that involves crossing
both the vascular endothelium and the glia limitans [4,5]. The
indirect detection of contrast-enhancing lesions (CEL) by Magnetic
Resonance Imaging (MRI) at the site of BBB disruption as a result of
contrast agent leakage into the CNS parenchyma is used as a
primary end point in MS clinical trials [6,7] and in the EAE mouse
model [8,9]. However, BBB disruption does not provide direct
evidence of immune cell trafficking into the CNS [10], and may
occur independently of the formation of new lesions [11]. There is
therefore a need to pursue supplemental MRI techniques, to gain a
more accurate and comprehensive view of the pathogenesis of CNS
inflammation. One strategy has been to employ iron oxide
nanoparticles [12], particularly as a means of studying immune cell
infiltration in the animal model of CNS inflammation, experimental
autoimmune encephalomyelitis (EAE) [13–16]. However the
application of paramagnetic nanoparticles is hampered by a number
of limitations, including the lack of an a priori knowledge of the
specific time of immune cell migration into the brain parenchyma.
Microscopic MRI (mMRI or MR histology) – defined as MRI
with a spatial resolution ,100 mm [17,18] – is one means of
amplifying image detail in order to observe even minor changes in
brain pathology during the course of disease. MRI resolution
depends on several factors including magnetic field strength,
gradient strengths and digital resolution, but the main limiting
factors are RF coil sensitivity and signal-to-noise ratio (SNR) [19].
Upon reducing voxel size to amplify spatial resolution, a loss in
SNR is to be expected. This loss can be considerably compensated
for by increasing signal averaging: this produces images with an
impressive level of microscopic detail as shown in ex vivo fixed brain
tissue samples [20]. However, increased signal averaging comes at
a cost in scan time, and is hence not practical for studies with
anesthetized animals. This along with the presence of movement
artifacts makes it inherently difficult to achieve sufficient resolution
to visualize brain pathology in vivo.
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One approach to maximize effective spatial resolution is to
increase signal sensitivity with cryogenically-cooled RF detection
devices that boost SNR, the currency spent for image resolution
and image quality [21]. Recently, RF coils made of supercon-
ducting material have been developed for animal micro-imaging,
which reduce coil resistance and thermal noise and therefore
increase SNR by up to a factor of up to 2.9 [22]. In essence such a
system increases the field strength virtually by a factor of at least 2,
according to MR principles, but without the disadvantages
associated with higher field strengths, such as stronger suscepti-
bility artifacts, B0 inhomogeneities and shorter wavelengths. The
effectiveness of this approach has been demonstrated in the
healthy mouse brain [23].
Realizing the capabilities of mMRI, we focused here on high
spatial resolution imaging of mice brain during the course of EAE
in an attempt to visualize inflammatory pathology in vivo prior to
and during commencement of disease. The ultimate aim of this
study was to distinguish cellular infiltrates in microscopic detail at
an early phase of disease. In this first study applying cryogenic MR
technology to EAE, we demonstrate that brain pathology can be
detected even without the use of contrast agents and show
excellent correspondence between mMRI findings and conven-
tional histology.
Results
Early detection of EAE pathology with high resolution
cryogenic imaging
Using a cryogenically-cooled RF coil, we performed high
spatial resolution brain imaging in EAE mice prior to and upon
commencement of disease (Figure S1). The mMRI performed
enabled us to detect lesions (as defined in Methods) already prior
to clinical manifestation of disease. Using a T2 weighted (T2W)
TurboRARE sequence that results in better contrast between
grey and white matter boundaries, we observed lesions in
multiple regions of the EAE mouse brains, particularly the
cerebellum, cerebral cortex and subcortical regions (thalamus
and striatum). Figure 1A shows the anatomical distribution of
the detected lesions as well as the time point of their first
detection (relative to the starting point of disease). Out of 9
immunized mice, all of which developed EAE, 7 mice exhibited
lesions in the brain (Figure S2). The average EAE score for all 9
mice was 1.760.7 (6 S.D.) and the average day of onset was
11.261.6 days (6 S.D.) with a range of 9–14 days post
immunization. All mice were scanned 5 days post immunization;
thus between 4–9 days prior to disease onset. Notably, lesions
could be detected as early as 3 days (d-3) prior to the appearance
of disease manifestations (Figure 1A). No lesions were observed
earlier than 3 days prior to clinical manifestations. Lesions in the
cerebellum were the most common, occurring between 1 to 3
days prior to onset of disease (Figure 1A, Figure 1B and
Figure S3). The T2W images shown in Figure 1B and Figure
S3 represent the structural changes occurring in the cerebellum
in a mouse during the 4–5 days prior to disease onset (d-5 – d0)
in comparison to baseline measurements (d-14) that were carried
out prior to immunization. Hyperintense lesions in the white
matter of the cerebellar Arbor vitae were already evident 2 days
prior to neurological symptoms (d-2, upper and middle arrow
head) and prominent on d-1 (along upper and lower arrow-
heads). Signal extinction that is indicative of cellular involvement
became apparent on d-1 (dotted islands) but was more
prominent upon onset of clinical symptoms (d0). To illustrate
the potential for quantitative assessment of the lesions, we
generated images in which we subtracted control baseline scans
from scans showing brain pathology as changes in signal
intensity (Figure S4A).
Figure 1. Anatomical distribution and evolution of lesions. EAE mice (n = 9) were immunized with PLP139–151 peptide (EAE induction) and
scored for neurological symptoms on a daily basis. Micro MRI was performed daily starting from d5 post immunization. (A) Shown are seven mice (1–
7) exhibiting lesions within the brain – specifically cerebral cortex, cerebellum and subcortical areas (thalamus and striatum) – prior to or during onset
of disease. The lower axis indicates the time-points prior to commencement of neurological symptoms (d0). (B) T2W images showing the evolution of
cerebellar lesions (arrowhead) from baseline (pre EAE induction) 14 days prior to disease manifestation (d-14) until disease onset (d0). Arrowheads
depict enhancement of signal intensity in the white matter over time and dotted islands depict signal extinctions in the vicinity.
doi:10.1371/journal.pone.0032796.g001
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Hypointense lesions on T2W images represent cellular
infiltrates
Early during disease progression, even prior to the onset of
clinical manifestations, we also observed lesions in the cortex.
Figure 2 illustrates a representative mouse at onset of clinically
observable signs of disease. Although major anatomical structures
including the corpus callosum, striatum, ventricular system and
hippocampus could be clearly resolved with T1 weighted (T1W)
scans (Figure 2A), no inflammatory pathology was observed with
this method. T2W imaging, on the other hand, revealed focal
hypo-intense lesions in multiple regions of the inflamed brains,
mostly in the cerebellum (Figure 1B) but also in the somatosen-
sory cortex (Figure 2B). T2* weighted (T2*W) imaging revealed
the signal extinctions observed by T2W imaging as punctate
lesions, with greater detail and in association with intracortical
vessels (Figure 2C and Figure 3A). We observed venous
irregularities within the cortex in 3 out of the 7 mice that
exhibited lesions in the brain. The irregularities were observed one
day prior to symptoms or upon initiation of symptoms. Processing
of T2*W phase maps for susceptibility weighted imaging (SWI)
[24] has been employed in MS lesions to reveal superior detail in
small anatomical structures such as the venous vasculature and
structural variations within gray and white matter [25]. SWI of the
phase maps derived from T2*W imaging yielded excellent
visualization of the small venous irregularities and enhanced
contrast between normal tissue, focal inflammatory lesions and the
microvasculature as highlighted in Figure 3B. To make a more
objective assessment of these structural changes we subtracted the
images showing pathology from images obtained at baseline, prior
to EAE immunization (Figure S4B). Notably, the structural
irregularities observed in T2W or T2*W images corresponded
with areas of inflammatory pathology – both in cerebrum
(Figure 3C) and cerebellum (Figure 3D) – as revealed by
conventional hematoxylin and eosin (H&E) histology. H&E stains
corroborate the mMRI data and conform to the expected pattern
of pathology in the EAE model. The EAE model has been
extensively characterized, and it is well established that the lesions
are comprised of immune cells, especially CD4+ T cells. Indeed,
the lesions that we could visualize with mMRI show the same
appearance and localization characteristics of CD4+ T cells
(Figure 3D). The clear correlation between the MRI data and the
histology underscores the utility of microscopic MRI to reveal
histologically relevant pathology in vivo [24,25].
Contrast enhanced lesions in close proximity to
ventricular system
Gadolinium contrast agents are frequently used in EAE
studies, and Gd CEL have a typically diffuse appearance. T1W
imaging post contrast (0.2 mmol/kg Gd-DTPA, Magnevist,
Bayer-Schering Pharma AG, Berlin, Germany) revealed diffuse
CEL (Figure 4A and Figure 4B) in all 7 mice exhibiting
hyper- or hypo- intense lesions in the brain. These CEL,
although more diffuse, corresponded in location to the T2W
lesions shown by mMRI (Figure 1, Figure 2, Figure 3). This
result corroborates the interpretation that the changes in signal
intensities detected by T2W and T2*W microstructural MRI
demonstrates the potential of microscopic MRI to reveal brain
pathology with greater precision and detail than conventional
contrast agents.
In EAE mice with lesions close to the ventricles, administration
of Gd-DTPA enabled the visualization of the ventricular system
(Figure 4C). The contrast-enriched ventricular system was
visualized three-dimensionally together with the brain vasculature
by performing a 29-minute 3D FLASH sequence with flow
compensation (GEFC), typically employed for MR angiography,
with an isotropic spatial resolution of 59 mm (Figure 4C). An
overlay of the maximum intensity projections (MIP) of the 3D
GEFC images with the MIP of post contrast T1W MDEFT CEL
images shows the spatial relationship of the contrast-enhanced
parenchyma (due to BBB disruption) with the ventricles and
cerebral vasculature (Figure 4D). The visualization of the
ventricular system together with the vasculature post contrast
was only visible in EAE mice with periventricular lesions and was
not visible in healthy non-immunized mice (Figure S5). While the
precise mechanism still needs to be determined, these results
suggest that an inflammation-induced disruption of the blood-
cerebrospinal fluid barrier might lead to extravasation of contrast
agent into the ventricular system.
Discussion
Experimental autoimmune encephalomyelitis is an animal
model widely employed to examine the basic biology of CNS
inflammatory processes, and to evaluate the effectiveness of
nascent therapeutic approaches for multiple sclerosis [26–31]. In
particular, EAE studies focusing on the early stages of brain
inflammation have revealed new insights on the mechanisms
Figure 2. High resolution MRI reveals focal hypo-intense inflammation in the cerebral cortex of EAE mice. (A) T1W horizontal scan
using an MDEFT sequence (TR/TE/TI 2600/3.9/950 ms, FOV 18618 mm, Matrix 3846384, 2 averages) for 16 slices (400 mm slice-thickness). (B) T2W
imaging using a TurboRARE sequence (TR/TE 3000/36 ms, FOV 18618 mm, Matrix 3846384, RARE-factor 8) with same geometry and resolution as for
T1W MDEFT. (C) T2*W imaging using a FLASH multislice sequence (TR/TE of 473/18 ms, FOV 18618 mm, acquisition Matrix 5126256, reconstruction
Matrix 5126512) with same slice thickness as in A and B.
doi:10.1371/journal.pone.0032796.g002
Identification of Cell Infiltrates in EAE by mMRI
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e32796
involved in the different waves of immune cell entry during
evolution of disease [32].
To gain a comprehensive and longitudinal view of brain
inflammation – particularly during the early stages of EAE –
methods employing high resolution brain imaging would be
advantageous. Several studies in EAE employing MRI have
significantly contributed to our understanding of the pathology of
brain inflammation [8,16,33,34]. However, in longitudinal MRI
studies (eg. to follow pathology during the course of EAE) one
main limiting factor is a restriction in the number of animals that
can be employed due to the length of each scanning procedure. To
overcome this, methods that increase SNR will be beneficial to
enable shorter scans. The gain in SNR achieved by cryogenically-
cooled systems that reduce thermal noise [22] is a major advantage
for studies with animal models for two main reasons: (i) it enables
the acquisition of images with greater spatial resolution within
reasonable scan times; and (ii) it facilitates the imaging of larger
numbers of animals with standard spatial resolution but within
shorter times. Depending on the design of the study it is possible to
compensate between both strengths.
The advantages and feasibility of cryogenically cooled coils –
particularly to image mouse brain anatomy – has already been
demonstrated at 4.7T [35] and 9.4T [22,23]. The scan time
required using a conventional room-temperature coil to observe
early pathological changes in the EAE brain (23 min for T2W
imaging, 24 min for T2*W imaging) was at least three times longer
than that of the currently employed cryogenically cooled coil
(5 min for T2W imaging, 8 min for T2*W imaging) using the
same magnetic field strength, considering the necessity to increase
the number of excitations (NEX=16 for RT coil compared with
NEX=1 for cryo coil) (Figure S6).
Handling of the currently available MRI cryogenic RF coils –
which evolved from NMR-spectroscopy [21] – has significantly
improved in recent years, and indeed is quite similar to any
conventional RT RF-coil. One major drawback of the cryogenic
probe used in this study is the transmission(TX)/reception(RX)-
coil design, which leads to an inhomogeneous excitation field
[22,35]. The non-uniform excitation field needs to be taken into
account when applying quantification techniques such as relaxo-
metry or spectroscopy, as well as magnetisation transfer ratio
(MTR). Due to the variation of the flip-angle throughout the
sample, the reference gain has to be carefully adjusted for the
volume of interest to minimize these changes. In this case a RX-
only design with a conventional actively de-tuned TX volume
resonator for a homogeneous excitation would be beneficial [36].
The effective anatomical resolution we employed in this study is
almost an order of magnitude higher than that attainable in
human brain imaging using clinical MRI scanners. Using this
technology we observed structural changes in EAE brains – in
regions including the cerebellum and cerebral cortex – prior to the
onset of neurological symptoms. These detailed and highly
resolved morphological changes were corroborated by subsequent
histological examination, which showed clear evidence of
infiltrated immune cells. The general trend in lesion distribution –
Figure 3. T2*W hypo-intense regions correspond to cellular infiltrates detected by histology. (A) Coronal T2*W imaging using the FLASH
multislice sequence (22 slices with slice thickness of 500 mm). (B) Susceptibility weighted imaging (SWI) of T2*W scans using fully-automated post-
processing by ParaVision 5.1 (Bruker, Ettlingen, Germany). (C) Cellular infiltrates in cerebral cortex; the overview of the H&E histology is overlaid with a
coronal slice (plate 41) from Franklin K.B.J., Paxinos G: The Mouse Brain in Sterotaxic Coordinates. Academic Press; 2007 with kind permission from
Elsevier. (D) Cellular infiltrates in cerebellar white matter lesions illustrated by CD4+ immunostaining and H&E staining.
doi:10.1371/journal.pone.0032796.g003
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with the cerebellum being the predominant site of damage in the
brain – is in agreement with the ascending pattern of EAE. Disease
progression in EAE shows a typical course of ascending paralysis,
accompanied by inflammatory pathology that proceeds from the
spinal cord initially affecting the tail and hind limbs, and
subsequently precipitating complete paralysis. With this cryogeni-
cally-cooled system we were able to apply imaging protocols for
high spatial resolution (as small as 356356400 mm), good grey
matter–white matter distinction and high SNR with scan times not
exceeding 15 min. The entire scanning protocol presented herein
requires at most 60 min pre contrast and 60 min post contrast, and
is therefore suitable for both longitudinal and cross-sectional in vivo
studies, with acceptable sample sizes.
Importantly, we were able to identify the presence of
inflammatory cells within the brain parenchyma without the
necessity of Gd-DTPA contrast agents. In contrast to the typical
diffuse lesions revealed by Gd enhancement, the lesions detected
by mMRI were more focused and more clearly demarcated. This
represents a clear advantage of the cryogenic coil over the previous
technology, as the ability to detect focal lesions by mMRI offers the
potential for more precise quantification of inflammation severity,
leading to more quantitatively robust EAE studies. However
contrast agents are still powerful tools since they provide clear
evidence of BBB disruption, although leakage of contrast agent in
the parenchyma does not give definitive evidence of parenchymal
damage. In situations where structural changes observed in the
brain with mMRI are not accompanied by contrast enhancement,
it is reasonable to speculate that immune cells may have
penetrated the vascular endothelium thereby entering the
pervascular spaces, but have not yet breached the glia limitans
and infiltrated into the brain parenchyma. Such perivascular-
restricted lesions are widely seen at the histological level in EAE
but have not yet been detected by MRI. The possibility of mMRI
with the cryogenic coil to detect such lesions, which are by
definition not detectable by Gd leakage into the parenchyma,
offers the potential for future investigations to observe pathological
processes that would otherwise be invisible, and underscores the
importance of this technology for MS research.
Another distinct advantage of the cryogenic RF coil for MS
research is the possibility to include magnetic resonance
angiography in the scanning protocol, in a quick and efficient
manner, to monitor changes in the vasculature over the course of
disease. Indeed, the present study represents the first application of
MR angiography in the mouse EAE model. The observation of
leakage of contrast agent into the ventricular system early in
disease is interesting, in light of recent reports highlighting the
importance of the choroid plexus [30] and the involvement of the
circumventricular organs in EAE [37].
In summary, the visualization of cellular infiltrates by in vivo
mMRI provides an opportunity to follow neuroinflammatory
processes throughout disease progression. Thus in parallel to
conventional histological examination and in combination with
contrast agents, mMRI will be invaluable for longitudinal studies
investigating immune cell infiltration during brain inflammation
and evaluation of novel therapeutics. Future directions for mMRI
studies in EAE will involve the application of techniques – such as
T2 mapping and MTR – that provide valuable information on
water/lipid content and myelin integrity during lesion develop-
ment. These techniques have already been successfully employed
in a model of oligodendrogliopathy [38,39] and will complement
MR methods typically employed in EAE studies since they provide
further knowledge regarding the neurodegenerative component of
the disease.
Materials and Methods
Ethics Statement
Animal experiments were carried out in accordance with the
guidelines provided and approved by the Animal Welfare
Department of the LAGeSo State Office of Health and Social
Affairs Berlin (Permit G0172/10).
Active EAE
To actively induce EAE, 6–8 week old female SJL/J mice
(Janvier, France) were immunized subcutaneously with 250 mg
PLP139–151 purity .95% (Pepceuticals Ltd., UK) together with
Complete Freund’s Adjuvant and heat-killed Mycobacterium
Figure 4. Three dimensional reconstruction of lesions in
relation to the vascular and ventricular system. (A) Contrast-
enhanced lesions (CEL) in coronal sections visualized by post Gd-DTPA
contrast T1W MDEFT MRI (dotted line depicts horizontal slice in B). (B)
CEL in horizontal sections imaged by post contrast T1W MDEFT
(dotted line depicts coronal slice in A). (C) Maximum intensity
projections (MIP) of images collected by 3D-GEFC showing the
contrast-filled ventricular system and the cerebral vasculature (D)
Overlay of a CEL 3D model (depicted in red) calculated from MIP of
T1W MDEFT images on 3D ventricular and vascular system calculated
from MIP of 3D-GEFC images.
doi:10.1371/journal.pone.0032796.g004
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tuberculosis (H37Ra, Difco). Bordetella pertussis toxin (250 ng;
List Biological Laboratories, US) was administered intraperitone-
ally at days 0 and 2. Mice were assigned a clinical score daily: 0, no
disease; 1, tail weakness; 2, paraparesis; 3, paraplegia; 4,
paraplegia with forelimb weakness; 5, moribund or dead animals.
In vivo MRI
Shortly before and during the MR session, mice were
anesthetized using a mixture of isoflurane as inhalation narcosis
(0.5–1.5%), pressurized air and oxygen. All MRI-scans were
performed on a Bruker Biospec 9.4T USR94/20 (Bruker,
Ettlingen, Germany). Mice were imaged using a Transceiver
Mouse Brain CryoProbe (Z106543, 400 MHz, Bruker BioSpin
MRI, Ettlingen, Germany). The CryoProbe is a half-cylindrical-
shaped 2-channel transmit/receive quadrature-driven surface coil,
for full mouse-brain coverage with a maximum field of view of c.
30620620 mm. The temperature of the mice was regulated at
37uC. The breathing rate and temperature was monitored by a
remote monitoring system (Model 1025, SA Instruments Inc.,
Syracuse, New York, USA). Images were acquired using T1-
weighted (T1W), T2-weighted (T2W) and T2*-weighted (T2*W)
techniques. Slice positioning was kept fixed through longitudinal
brain examination: axial slices were positioned parallel to the base
of the brain, coronal slices were positioned perpendicular to axial
slices and covering the brain from the olfactory bulb/frontal lobe
fissure to the cervical spinal cord.
MRI sequences
Pre and post contrast T1W imaging was done with a Modified
Driven-Equilibrium Fourier Transformation sequence (MDEFT)
(3D MDEFT: TR/TE/TI: 3000/3.9/950 ms, FA 20u, matrix
3846384). Horizontal sections of the entire mice brain were
performed in 11 min at a spatial resolution of (476476400) mm3.
Coronal sections were performed in 15 min at a spatial resolution
of (476476500) mm3. As T1-enhancing contrast agent gadolinium
diethylenetriamine penta-acetate (Gd-DTPA, Magnevist, Bayer-
Schering Pharma AG, Berlin, Germany) was administered
intravenously at a concentration of 0.2 mmol/kg. T2W scans
(2D TurboRARE: TR/TE: 3000/43 ms, matrix 3846384) were
performed in 5 min with geometry and spatial resolution identical
to that of T1W imaging. To image brain tissue in association with
the microvasculature we applied a T2*W multislice fast low angle
shot (2D FLASH: TR/TE: 473/18 ms, FA 40u, matrix 5126512)
sequence with an in plane resolution of (35635) mm2. For
horizontal scans we used a slice thickness of 400 mm and 16 slices
for full brain coverage with a scan time of 8 min and for coronal
scans we used 22 slices of 500 mm with a scan time of 11 min to
image the whole mouse brain. For mice showing leakage of
contrast agent, a 29 min 3D FLASH sequence with flow
compensation (GEFC: TR/TE: 30/5.9 ms, matrix 51262566
256) was applied, for visualization of the vasculature and
ventricular system 1 hr after contrast injection at an isotropic
spatial resolution of 59 mm.
The following MRI sequences were used for the baseline scans,
prior to immunization: TurboRARE, MDEFT, 2D FLASH and
3D GEFC. Five days post-immunization, the mice underwent
daily horizontal and coronal T2W (TurboRARE) scans. If no
lesions or clinical signs were observed, the mouse was returned to
the home cage and scanned again the next day. If hypo- or hyper-
intense lesions were detected, then 2D FLASH and MDEFT pre-
contrast scans of that mouse were done immediately. The mouse
was then injected i.v. with Gd-DPTA, and post-contrast MDEFT,
TurboRARE and 3D GEFC scans were done (15, 45, and
55 minutes following contrast injection, respectively). If the mouse
did not show clinical signs, regardless of the observation of lesions,
it was returned to the home cage and scanned again the next day.
If the mouse did show clinical signs, this was the pre-defined
endpoint, the mouse was sacrificed on the same day, and the brain
extracted for histological comparison. Given the inherent
variability in the time of onset of EAE, we elected to use this
design (Figure S1), customized for each individual animal, rather
than use a pre-selected timetable.
Image analysis
Images from longitudinal experiments in mouse EAE were
analyzed by three individuals who were blinded towards disease
activity of corresponding mice. Lesions on T2W images were
defined as described for T2W lesions in MS patients [40]. Briefly,
lesions had to be clearly visible, non-artifactual areas of change in
the signal intensity (signal enhancement or extinction on the grey
background) of T2W images compared to baseline T2W images
(taken prior to EAE immunization). To generate susceptibility
weighted images post processing of the phase maps derived from
T2*W imaging for was performed by fully-automated reconstruc-
tion using ParaVision 5.1 (Bruker, Ettlingen, Germany).
Histology
After terminal anesthesia, mice were transcardially perfused
with 20 ml PBS, then with 20 ml zinc fixation solution (0.5% zinc
acetate, 0.5% zinc chloride, 0.05% calcium acetate). Brains were
then extracted and subsequently post-fixed in zinc solution for 3 d
at room temperature. The tissues were then cryoprotected by
incubation overnight at 4 degrees in 30% sucrose in PBS, then
embeded in O.C.T. and frozen in methylbutane with dry ice. The
tissues were cut into 12 um sections on a cryostat, and stained with
hematoxylin and eosin according to standard procedures. For
immunostaining, tissue sections were blocked with avidin, biotin,
and normal goat serum, then incubated overnight at 4uC with rat
anti-mouse CD4 antibody (Invitrogen). The sections were then
incubated with biotinylated goat anti-rat IgG antibody (Vector
Laboratories), then streptavidin-conjugated peroxidase, and visu-
alized with Vector NovaRED Peroxidase substrate (Vector
Laboratories) and counterstained with hematoxylin.
Supporting Information
Figure S1 Flow chart illustrating the design of the mMRI
study in EAE mice. Following a baseline scan, mice were
immunized and scanned daily (horizontal and coronal T2W MRI)
5 d post-immunization. More intensive scans were performed and
contrast (Gd-DPTA) was i.v. applied when lesions were detected
with T2W MRI.
(TIF)
Figure S2 EAE scores compared with day of lesion
occurrence. The neurological score of each mouse is plotted
against the day of first lesion occurrence (d-1 denotes that lesions
were first observed one day prior to onset of symptoms).
(TIF)
Figure S3 Cerebellar changes during course of EAE.
T2W images using a TurboRARE sequence (TR/TE 3000/
43 ms, FOV 18618 mm, Matrix 5126512 (3846384 for d-14),
RARE-factor 8) showing the evolution of cerebellar lesions from
baseline (pre EAE induction) 14 days prior to disease manifestation
(d-14) until disease onset (d0) including daily scans starting from
day 5 (d-5) prior disease onset. Dotted islands depict signal changes
in the white-matter of the cerebellum.
(TIF)
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Figure S4 Parenchymal and vascular changes following
EAE induction. (A) T2W images using a TurboRARE sequence
TR/TE 3000/43 ms, FOV 18618 mm, Matrix 5126512
(3846384 for baseline), RARE-factor 8). Top row: baseline;
middle row: pre-symptomatic image revealing a hyperintense
lesion in the cortex; bottom row: subtracted image. (B) SWI
processed T2*W images using a FLASH multislice sequence (TR/
TE of 473/18 ms, FOV 18618 mm, acquisition Matrix
5126512). Top row: baseline; middle row: pre-symptomatic
image showing vascular irregularities in the region of the T2
hyperintense lesion shown in (A); bottom row: subtracted image.
(TIF)
Figure S5 Maximum intensity projections (MIP) pre
and post contrast administration in a healthy non-
immunized mouse. (A) Pre-contrast MIP of a 3D-GEFC
sequence (TR/TE: 30/5.9 ms, matrix 51262566256). (B) Post-
contrast MIP of the same mouse.
(TIF)
Figure S6 Differences in quality and scan duration
between images showing cortical hypointense lesions
in EAE brains using either a cryogenically cooled coil (A,
C) or a room temperature (RT) 18 mm mouse-head
birdcage coil (B, D). (A) T2W images using a TurboRARE
sequence with cryogenic coil (TR/TE 3000/36 ms, FOV
18618 mm, Matrix 3846384) (B) T2W images using a TurboR-
ARE sequence with RT coil (TR/TE 2000/30 ms, FOV
24614 mm, Matrix 3006174) (C) T2*W images using a FLASH
multislice sequence with cryo coil (TR/TE of 473/18 ms, FOV
18618 mm, acquisition Matrix 5126512) (D) T2*W images using
a FLASH multislice sequence with RT coil (TR/TE of 473/
13 ms, FOV 24614 mm, acquisition Matrix 3306192).
(TIF)
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